The first crack in the belief that aging was unchangeable came from this pathway. When scientists discovered that dialing down insulin/IGF-1 signaling could DOUBLE a worm's lifespan, it proved aging is governed by specific, tweakable signals. This is where modern longevity genetics began.
Learning Objectives
- •Understand the insulin/IGF-1 signaling pathway
- •Learn why REDUCED signaling extends lifespan
- •Connect it to the FOXO longevity transcription factors
⚕️ Education, not medical advice
This course explains the biology of longevity pathways and the compounds studied to act on them. It is NOT medical advice or a recommendation to take any drug or supplement. Several compounds discussed are experimental or used off-label; decisions about them belong with a qualified clinician who knows your situation.
The growth-and-abundance signal
Insulin (which manages blood sugar) and IGF-1 (insulin-like growth factor 1, which drives growth) signal through a shared pathway often abbreviated 'IIS' (insulin/IGF-1 signaling). When food — especially carbohydrate and protein — is abundant, this pathway is active, telling cells to take up nutrients, grow, and divide. It's the body's primary 'times are good, build and grow' signal.
The landmark discovery: less signaling, more life
In the 1990s, researchers found that mutating a single gene in the worm C. elegans — daf-2, which encodes the insulin/IGF-1 receptor — MORE THAN DOUBLED its lifespan, and the long-lived worms stayed healthy. Reducing IIS, it turned out, extends lifespan across species (worms, flies, mice). This was revolutionary: it showed lifespan is controlled by a specific, modifiable signaling pathway, not a fixed clock.
FOXO: the longevity gene switch
How does lowering IIS extend life? When the insulin/IGF-1 pathway is QUIET, it releases a brake on a family of transcription factors called FOXO (daf-16 in the worm). Activated FOXO switches ON a broad program of protective genes — stress resistance, DNA repair, antioxidant defenses, and autophagy. So reduced growth signaling doesn't just slow growth; it actively turns on the cell's maintenance-and-defense machinery. FOXO is a master longevity switch.
ABUNDANT food → INSULIN/IGF-1 pathway ACTIVE → growth; FOXO held OFF
REDUCED signaling (daf-2 mutation, CR) → pathway QUIET → FOXO ON
│
protective genes: stress resistance, repair, autophagy
▼
longer, healthier lifeWhy some centenarians carry IGF-1-pathway variants
The worm findings echo in humans: studies of exceptionally long-lived people (centenarians) have found an enrichment of genetic variants affecting the growth-hormone/IGF-1 axis — generally in the direction of LOWER growth signaling. People with certain IGF-1-reducing conditions also show very low cancer and diabetes rates. It's human evidence pointing the same way the worm did: dialed-down growth signaling associates with longevity.
Insulin/IGF-1 signaling, by the numbers
- ▸Insulin/IGF-1 signaling (IIS) is the body's primary growth/abundance signal
- ▸Mutating the worm's IIS receptor (daf-2) more than doubles lifespan
- ▸Reduced IIS extends lifespan across worms, flies, and mice
- ▸Lower IIS activates FOXO transcription factors that switch on protective genes
Higher growth-factor (IGF-1) signaling is always better for health and longevity.
Reduced insulin/IGF-1 signaling, not increased, is associated with longevity across species (and in long-lived humans). High chronic growth signaling drives growth at the expense of the repair programs (via FOXO) that extend healthy lifespan.
Quick Check
What did mutating the worm's insulin/IGF-1 receptor (daf-2) do?
Quick Check
How does reduced insulin/IGF-1 signaling extend lifespan?
True or False
Studies of centenarians have found an enrichment of variants that lower growth/IGF-1 signaling.
Summary
- →Insulin/IGF-1 signaling (IIS) is the primary growth/abundance signal
- →Reducing IIS more than doubled worm lifespan — and extends life across species
- →Lower IIS activates FOXO, switching on protective repair and stress-resistance genes
- →Long-lived humans show enrichment of lower-growth-signaling variants
Closely tied to insulin/IGF-1 is the single most important growth switch inside the cell — and the target of the most robust longevity drug. Next: mTOR.